BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25732322)

  • 1. Consensus on the management of advanced medullary thyroid carcinoma on behalf of the Working Group of Thyroid Cancer of the Spanish Society of Endocrinology (SEEN) and the Spanish Task Force Group for Orphan and Infrequent Tumors (GETHI).
    Galofré JC; Santamaría Sandi J; Capdevila J; Navarro González E; Zafón Llopis C; Ramón Y Cajal Asensio T; Gómez Sáez JM; Jiménez-Fonseca P; Riesco Eizaguirre G; Grande E
    Endocrinol Nutr; 2015 Apr; 62(4):e37-46. PubMed ID: 25732322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consensus on management of advanced medullary thyroid carcinoma on behalf of the Working Group of Thyroid Cancer of the Spanish Society of Endocrinology (SEEN) and the Spanish Task Force Group for Orphan and Infrequent Tumors (GETHI).
    Grande E; Santamaría Sandi J; Capdevila J; Navarro González E; Zafón Llopis C; Ramón Y Cajal Asensio T; Gómez Sáez JM; Jiménez-Fonseca P; Riesco-Eizaguirre G; Galofré JC
    Clin Transl Oncol; 2016 Aug; 18(8):769-75. PubMed ID: 26687366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spanish consensus for the management of patients with anaplastic cell thyroid carcinoma.
    Gómez Sáez JM; Jiménez-Fonseca P; Santamaría Sandi J; Capdevila Castillón J; Navarro González E; Zafón Llopis C; Ramón Y Cajal Asensio T; Riesco Eizaguirre G; Grande Pulido E; Galofré Ferrater JC
    Endocrinol Nutr; 2015 Mar; 62(3):e15-22. PubMed ID: 25583658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis, treatment, and follow-up of medullary thyroid carcinoma: recommendations by the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism.
    Maia AL; Siqueira DR; Kulcsar MA; Tincani AJ; Mazeto GM; Maciel LM
    Arq Bras Endocrinol Metabol; 2014 Oct; 58(7):667-700. PubMed ID: 25372577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of medullary thyroid cancer.
    Ball DW
    Minerva Endocrinol; 2011 Mar; 36(1):87-98. PubMed ID: 21460789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor marker and measurement fluctuations may not reflect treatment efficacy in patients with medullary thyroid carcinoma on long-term RET inhibitor therapy.
    Kurzrock R; Atkins J; Wheler J; Fu S; Naing A; Busaidy N; Hong D; Sherman S
    Ann Oncol; 2013 Sep; 24(9):2256-61. PubMed ID: 23676418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of medullary thyroid carcinoma.
    Jiménez C; Hu MI; Gagel RF
    Endocrinol Metab Clin North Am; 2008 Jun; 37(2):481-96, x-xi. PubMed ID: 18502338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medullary thyroid carcinoma.
    Leboulleux S; Baudin E; Travagli JP; Schlumberger M
    Clin Endocrinol (Oxf); 2004 Sep; 61(3):299-310. PubMed ID: 15355445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medullary thyroid cancer.
    You YN; Lakhani V; Wells SA; Moley JF
    Surg Oncol Clin N Am; 2006 Jul; 15(3):639-60. PubMed ID: 16882502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Follow-up in Medullary Thyroid Carcinoma.
    Raue F; Frank-Raue K
    Recent Results Cancer Res; 2015; 204():207-25. PubMed ID: 26494391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The treatment of medullary thyroid cancer].
    Fujita T; Fujimori M
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1627-31. PubMed ID: 19838021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical management of medullary thyroid cancer.
    Mazeh H; Sippel RS
    Minerva Endocrinol; 2012 Dec; 37(4):329-34. PubMed ID: 23235189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medullary thyroid carcinoma.
    Pacini F; Castagna MG; Cipri C; Schlumberger M
    Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):475-85. PubMed ID: 20627492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and clinical spectrum of nonsecretory medullary thyroid carcinoma in a series of 839 patients with sporadic medullary thyroid carcinoma.
    Frank-Raue K; Machens A; Leidig-Bruckner G; Rondot S; Haag C; Schulze E; Lorenz A; Kreissl MC; Dralle H; Raue F; Schmid KW
    Thyroid; 2013 Mar; 23(3):294-300. PubMed ID: 22946486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular genetics of medullary thyroid carcinoma: the quest for novel therapeutic targets.
    Cerrato A; De Falco V; Santoro M
    J Mol Endocrinol; 2009 Oct; 43(4):143-55. PubMed ID: 19383830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medullary thyroid cancer secreting carbohydrate antigen 19-9 (Ca 19-9): a fatal case report.
    Elisei R; Lorusso L; Romei C; Bottici V; Mazzeo S; Giani C; Fiore E; Torregrossa L; Insilla AC; Basolo F; Guerini A; Menghi A; Poletti A; Cugudda L; Vitti P
    J Clin Endocrinol Metab; 2013 Sep; 98(9):3550-4. PubMed ID: 23861463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: a useful tool for patient risk stratification.
    Mian C; Pennelli G; Barollo S; Cavedon E; Nacamulli D; Vianello F; Negro I; Pozza G; Boschin IM; Pelizzo MR; Rugge M; Mantero F; Girelli ME; Opocher G
    Eur J Endocrinol; 2011 Jun; 164(6):971-6. PubMed ID: 21422198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cabozantinib for the treatment of progressive metastatic medullary thyroid cancer.
    Krajewska J; Olczyk T; Jarzab B
    Expert Rev Clin Pharmacol; 2016; 9(1):69-79. PubMed ID: 26536165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Medullary carcinoma of the thyroid: diagnosis and therapy].
    Giuffrida D; Ferraù F; Bordonaro R; Mattina M; Priolo D; Aiello RA; Cordio S; Motta S; Failla G
    Clin Ter; 2000; 151(1):29-35. PubMed ID: 10822879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and surgical dilemmas in hereditary medullary thyroid carcinoma.
    Allen SM; Bodenner D; Suen JY; Richter GT
    Laryngoscope; 2009 Jul; 119(7):1303-11. PubMed ID: 19444888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.